Oncology-specialized · CTCAE-aligned
Your expertise, extended
to every moment of treatment
Cureety's oncology-specialized remote monitoring platform transforms patient feedback into structured intelligence, so you can intervene early, with confidence, and focus on the patients who need you most.
70K+
Patients proactively supported with Cureety so far
3,500+
Healthcare professionals using Cureety in their daily clinical practice
250+
Cancer centers globally trust
our oncology-specialized platform
The Cureety Solution
Extending your reach beyond the clinic walls
Patients spend 95% of their time outside the clinic. Cureety captures what happens between visits and surfaces structured, prioritized insights so your team is always ready to act.
Cureety amplifies your team's capacity to deliver precise, coordinated cancer care — so the right patient gets the right attention at the right time.
Visibility between visits
Replace subjective feelings with objective clinical data. CTCAE-aligned grades give you a continuous view of toxicity and functional impact.
Amplify clinical capacity
Close the gap between rising patient volumes and limited clinical hours — without adding headcount or burdening staff.
Precision care for advanced therapies
Tailored protocols designed for ADCs, CAR-T, bispecifics, and oral therapies — never therapy-agnostic.
Early detection, proactive intervention
Distinguish routine side effects from clinically relevant signals. Reduce avoidable hospitalizations and unscheduled calls.
Infusion readiness before they arrive
Combine automated lab results with patient-reported toxicity ahead of treatment. Optimize chair utilization and prevent drug waste.
Empowered patient self-management
NCCN and ASCO-aligned recommendations empower patients to manage symptoms proactively and stay on track with treatment.
Configurable to your organization
Our experts map your workflows. Technology follows your clinical logic — not the other way around.
Expanding precision care across sites
Clinically aligned monitoring across all sites supports an equitable model — access not determined by location.
Meet Cureety
Clinical intelligence for precision care
Cureety helps you deliver context-aware, treatment-specific monitoring and care for patients that reflects the reality of modern oncology. We move beyond generic checklists to address specific treatments, specific risks, and specific patients.
Meet Cureety
The same symptom does not always carry the same risk
Cough - Grade 1
Patient
on Paclitaxel
Low-risk signal
Cough - Grade 1
Patient on Trastuzumab Deruxtecan
ILD Risk
A patient with a Grade 1 cough on Paclitaxel may not have a high risk. The same symptom in a patient receiving Trastuzumab Deruxtecan could indicate a high risk of interstitial lung disease. Cureety's intelligence layer ensures triage is aligned with the regimen's toxicity profile.
Over 1 million questionnaires completed · validated algorithm with 94.4% specificity and 95.8% sensitivity for critical classifications. {tooltip} Positea-va study. The algorithm correctly identifies 95.8% of patients classified as "critical" by experts. Only 5.6% false positives.Peer-reviewed and validated over 400 patients. {a:https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.1605}Source{/a}{/tooltip}
Meet Cureety
Triage that understands
clinical context
Cureety's triage intelligence reviews every symptom against the patient's specific treatment, cancer type, and clinical history. The result: less noise; more accurate, earlier detection of situations that matter.
Clinically validated accuracy
94.4% specificity and 95.8% sensitivity for critical classifications. Peer-reviewed and validated over 400 patients. {tooltip} Positea-va study. The algorithm correctly identifies 95.8% of patients classified as "critical" by experts. Only 5.6% false positives.Peer-reviewed and validated over 400 patients. {a:https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.1605}Source{/a}{/tooltip}
Continuously evolving protocols
Our library is systematically updated for every new regimen to reflect its unique toxicity profile.
Global patient context
Cancer type, treatment stage, and unique medical history — high-fidelity data that reflects the whole patient.
Integrated patient signals
Option to combine patient reported symptoms, vitals and pathology results.
60%
Fewer red alerts than most PRO-CTCAE based systems. Your team responds to signals, not noise. Every alert is meaningful. {tooltip}On average, 60% fewer red alerts are issued than most PRO-CTCAE based systems depending on drug class (4,78 % red, 21,3 % orange on average, on Argos II 2026, based on 2 459 277 AE the 06/04/26) vs, for example, 12,2% red and 27,5% orange alert using PRO-CTCAE (Realworld experience in 33 centres in France and in Belgium - Franzoi, Maria Aliceet al. The Lancet Regional Health – Europe, Volume 44, 101005){/tooltip}
Meet Cureety
Make sure your patients are fit for treatment before they arrive
For patients on IV treatment, the question before every infusion is simple: is this patient well enough today? Answering it shouldn't require a morning of phone calls — or wait until the patient has already arrived.
Anticipated treatment readiness
Automated prompts ensure patients communicate their clinical status and lab test results ahead of their next cycle — powering a decision-ready dashboard for your team.
Streamlined operational efficiency
Eliminate hours of manual planning with automated calendar updates designed to handle even the most complex oncology treatment regimens.
Measured Impact
Impact where it matters
to your organization
−61%
Reduction in hospitalization
stays through proactive toxicity detection {tooltip}Minerva Study, p value = 0.02, CNRC{/tooltip}
−37%
Treatment discontinuation
at 3 months {tooltip}Steve consulting report for French Health Ministry 2025, p=0.0036{/tooltip}
CTCAE
Symptom data mapped directly to CTCAE v6.0 grading, removing ambiguity from clinical decisions
-33%
time to treatment start {tooltip}Measured at Institut Godinot after 1 year with Cureety and 1,200 patients: from 21 to 14 days {/tooltip}
66%
Decrease in inbound clinic calls through digital symptom pathways {tooltip}Minerva Study, p value = 0.02, CNRC{/tooltip}
<90min
Median response time for critical alerts {tooltip}Measured at Institut Godinot after 1 year with Cureety : on 1200 patients with 3 nurses with other duties as well{/tooltip}
-50%
Reduction in late cancellations and no-shows {tooltip}Measured at Institut Godinot after 1 year with Cureety : 1,200 patients with 3 nurses with other duties as well, nov 2025{/tooltip}
EHR sync
Automated care coordination that syncs patient reminders and data directly with your existing EHR infrastructure
Reimbursement
Structured data streamlined Medicare reimbursement and value-based care billing
Less waste
Drug wastage reduced by identifying unfit patients before preparation
RWD
Generate high-fidelity real-world data essential for research and safety monitoring
Envision
Improve long-term clinical and financial outcomes by moving from reactive to proactive patient management
Empowering better oncology care